Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 3,491 | 0 | 90 | 7,617 | 216 |
| Gross Profit | 3,491 | N/A | 90 | 7,617 | 216 |
| Operating Expenses | 1,946 | 2,631 | 3,382 | 4,395 | 2,810 |
| Operating Income | 1,546 | -2,631 | -3,293 | 3,223 | -2,593 |
| Other Income | 237 | 412 | 224 | 291 | 312 |
| Pre-tax Income | 1,782 | -2,219 | -3,068 | 3,514 | -2,282 |
| Income Tax | 0 | N/A | -1 | 0 | 1 |
| Net Income Continuous | 1,782 | -2,219 | -3,068 | 3,514 | -2,282 |
| Net Income | $1,782 | $-2,219 | $-3,069 | $3,514 | $-2,282 |
| EPS Basic Total Ops | 0.32 | -0.41 | -0.57 | 0.66 | -0.42 |
| EPS Basic Continuous Ops | 0.33 | -0.41 | -0.57 | 0.66 | -0.43 |
| EPS Diluted Total Ops | 0.35 | -0.44 | -0.57 | 0.66 | -0.43 |
| EPS Diluted Continuous Ops | 0.33 | -0.41 | -0.57 | 0.66 | -0.43 |
| EPS Diluted Before Non-Recurring Items | 0.33 | -0.44 | -0.56 | 0.66 | N/A |
| EBITDA(a) | $1,443 | $-2,790 | $-3,480 | $3,016 | $-2,788 |